Wake therapy and triple chronotherapy

1. Introduction

Version followed: wake therapy and combined ("triple") chronotherapy as hospital procedures delivered by a psychiatric team, described from the ISBD task force review and practice recommendations (Gottlieb et al., 2019), the Wirz-Justice, Benedetti and Terman clinician's manual (Karger, 2009; publisher description only), the San Raffaele (Milan) ward programme as its leading clinician's institute describes it, and two meta-analyses. This guide is written for the psychotherapist working alongside that team. It contains no wakefulness schedules, sleep-timing protocols, light parameters or drug doses; those belong to the treating psychiatrist or sleep specialist.

What it is. Wake therapy (therapeutic sleep deprivation) means keeping a depressed patient awake for a whole night (total sleep deprivation) or part of it (partial sleep deprivation) under clinical supervision. It is described as "the only established antidepressant therapy that acts within hours", but the effect is unstable: most responders relapse after the next night's recovery sleep or even a short nap [source: Hemmeter et al., 2010]. Triple chronotherapy combines sleep deprivation with bright light therapy and a sleep phase advance (moving the sleep period and then returning it towards the usual time), in order to hold on to the rapid response [source: Gottlieb et al., 2019; UCL meta-analysis]. The publisher's description of the clinician's manual calls wake therapy "the fastest antidepressant known" and presents combined chronotherapeutics as a non-drug synthesis of light and wake therapy for bipolar and unipolar depression [source: Wirz-Justice et al., 2009, publisher description].

Core idea of change. Chronotherapeutics is defined as controlled exposure to environmental stimuli that act on biological rhythms; these are said to act on the same neurotransmitter systems and brain regions as antidepressant drugs, with rapid but transient effects that can be stabilised by combining techniques or adding usual medication [source: Sleep Medicine Reviews 2007 review "Chronotherapeutics in a psychiatric ward", authors not confirmed]. The added components aim to reset and stabilise circadian rhythms so the response does not collapse on recovery sleep [source: UCL meta-analysis].

Who delivers it and where. A psychiatric team, almost always on an inpatient ward: nearly all studies in the most recent meta-analysis were inpatient, with a single outpatient case series [source: UCL meta-analysis]. Francesco Benedetti's group at San Raffaele Hospital, Milan, is described as having made chronotherapeutics an everyday ward method, with a focus on bipolar disorder, starting from sleep deprivation and adding sleep phase advance, light therapy and medication [source: CET, Benedetti profile]. US work includes the randomised trial by Wu and colleagues (2009), graded as the one Level II study in the ISBD review [source: Gottlieb et al., 2019], and an open pilot of adjunctive chronotherapy in suicidal depressed inpatients (Sahlem et al., 2014), associated with rapid improvement in mood and suicidality when added to standard care [source: NYSPI protocol #7361 background; the Sahlem paper's details are [uncertain]].

Regulatory and guideline status. As of October 2026, per the sources, it is a clinical procedure, not a licensed drug or device, and none of those sources describes a regulatory approval for it [uncertain]. The ISBD task force rated the evidence as "a low level of evidentiary support", mostly uncontrolled studies, and said sleep deprivation may be considered when more established options have failed or are not tolerated, or when a rapid response is needed [source: Gottlieb et al., 2019]. CET's summary of that review reports: recommended for acute bipolar depression; not recommended for acute mania (expert consensus treats it as contraindicated); no recommendation for maintenance [source: CET, Gottlieb 2020]. A bipolar meta-analysis notes that guidelines it cites treat sleep deprivation as a third-line adjunct in major depression and as experimental in bipolar depression [source: Ramirez-Mahaluf et al., 2020]. CANMAT 2016 reviewed sleep deprivation among complementary physical treatments; the abstract opened did not give its line of treatment [uncertain]. No NICE recommendation on wake therapy is described in the sources [uncertain].

2. Framework

This is a medical procedure run by the psychiatric team; the phases below describe the treatment course and where the psychotherapist fits. Phase labels are a [synthesis] of how the sources describe the course.

Phase 0: Identification and referral (outpatient therapy or ward). Goal: recognise a client for whom a psychiatric opinion on chronotherapy may be relevant (severe or treatment-resistant depressive episode, need for rapid response, bipolar depression already on a mood stabiliser) and route the question to the treating psychiatrist [synthesis, drawing on the selection features in Gottlieb et al., 2019 and Hemmeter et al., 2010]. Move on when the psychiatrist has agreed to assess.

Phase 1: Medical assessment, selection and consent (psychiatric team). Goal: confirm diagnosis and episode type, exclude contraindications (acute mania or mixed state; epilepsy; unstable medical illness; for light, retinal conditions), review co-treatment, rate baseline mood and suicidality, and obtain informed consent [source: Gottlieb et al., 2019; Hemmeter et al., 2010; NYSPI protocol #7361]. Psychotherapist: consent support, preparation. Move on when the team has accepted the patient and consent is documented.

Phase 2: Acute chronotherapy course (inpatient, days). Goal: induce a rapid antidepressant response with sleep deprivation, then try to hold it with the stabilising components (sleep phase advance, light, medication). Response is reported within 1 to 2 days, and studies assessed outcome at about day 5 to 7 [source: UCL meta-analysis]. The team rates mood repeatedly (studies used HRSD, MADRS and visual analogue scales) [source: Gottlieb et al., 2019]. Psychotherapist: supportive contact, watching for mood switch and suicidality, passing observations to the team.

Phase 3: Consolidation and transition (weeks). Goal: keep the response through continued light, sleep-wake regularity and medication as the prescriber decides; effects in randomised trials appeared to fade by weeks 7 to 9, and durability is unresolved [source: UCL meta-analysis]. Psychotherapist: relapse planning, rhythm-stabilising psychotherapy, discharge planning.

Phase 4: Maintenance and relapse prevention (months). Goal: prevent recurrence. The ISBD review made no recommendation for sleep deprivation as maintenance; it reports evidence for interpersonal and social rhythm therapy (IPSRT) in hastening recovery and preventing relapse in bipolar disorder [source: Gottlieb et al., 2019; CET, Gottlieb 2020]. Psychotherapist: core treatment phase for psychotherapy, in collaboration with the prescriber.

Session count and format: there is no fixed number of psychotherapy sessions in the sources [uncertain]. A reasonable pattern is one or more preparation sessions, brief supportive contacts during the inpatient course where the ward allows, and regular sessions afterwards [synthesis].

3. Guiding principles

Hospital procedure, never self-administered. Sources describe it as given "under careful medical supervision" [source: Sleep Med Rev 2007 abstract]. Practical meaning: never suggest, coach or help a client stay awake at home to lift mood; route the question to the psychiatrist.
The psychiatrist owns the protocol. Practical meaning: you do not discuss schedules, light settings or medication; you support, observe and report [synthesis].
Rapid, but fragile. The response can collapse after recovery sleep or naps; reported relapse is around 83% in unmedicated responders [source: Hemmeter et al., 2010; Gottlieb et al., 2019]. Practical meaning: prepare the client for a possible dip so it is not read as personal failure.
Bipolar safety first. Contraindicated in acute mania and mixed states; switch rates are low overall (about 1% of 388 bipolar patients in one meta-analysis, 0 to 5% in most studies) but higher in rapid cycling [source: UCL meta-analysis; Gottlieb et al., 2019; Hemmeter et al., 2010]. Practical meaning: screen and monitor for hypomanic signs at every contact and report them the same day.
Epilepsy is the main medical contraindication. Sleep deprivation "has a high risk of inducing seizures" in people with epilepsy [source: Hemmeter et al., 2010]. Practical meaning: make sure the team knows about any seizure history, including childhood or alcohol-related seizures [synthesis].
Suicide risk is monitored throughout. Suicidality can improve rapidly [source: Hemmeter et al., 2010; Gottlieb et al., 2019], but a relapse after a brief lift is a recognised moment of risk [synthesis]. Practical meaning: update the safety plan before, during and after the course.
Adjunct, not replacement. Studies used it alongside usual medication; lithium and other co-treatments were named as helping to prolong response and reduce switching [source: Gottlieb et al., 2019; Ramirez-Mahaluf et al., 2020]. Practical meaning: never frame chronotherapy as a way off medication; route any wish to change medicines to the prescriber.
Honest about evidence. Low-quality, mostly inpatient and short-follow-up evidence [source: Gottlieb et al., 2019; UCL meta-analysis]. Practical meaning: give balanced information that supports a free choice, without overselling.
Rhythm stability carries the gains. Practical meaning: psychotherapy after the course focuses on regular sleep-wake and social rhythms, in line with IPSRT [source: Gottlieb et al., 2019 on IPSRT; application here is synthesis].
Consent is a process. Practical meaning: check understanding again before and during the course; the patient can stop at any time [source: NYSPI protocol #7361 on withdrawal; synthesis for the ongoing check].

4. Intervention inventory

Part A describes, at a descriptive level only, what the psychiatric team does, so you can explain it and spot problems. Part B covers your own interventions. Nothing in Part A is an instruction for you or the client to carry out.

Part A1. Wake therapy (therapeutic sleep deprivation), as the team delivers it

Purpose: a rapid antidepressant effect within hours, in roughly 40 to 60% of depressed patients; a meta-analysis of 61 studies reported marked response in 59% [source: Hemmeter et al., 2010].
What happens (descriptive): the patient stays awake through all or part of a night under ward supervision. Variants are total and partial sleep deprivation; selective REM sleep deprivation was judged impractical for routine use [source: Hemmeter et al., 2010; Gottlieb et al., 2019]. Brief unnoticed microsleeps and naps during the wake period were linked to weaker response and relapse, and nursing staff did not always notice microsleeps [source: Hemmeter et al., 2010]. Exact timing and length are set by the team and are not described here.
Who responds (as sources describe): typical diurnal variation (worse in the morning, better in the evening), typical or melancholic features and bipolar depression are linked to better response; atypical features such as hypersomnia and daytime tiredness to poorer response [source: Hemmeter et al., 2010; Gottlieb et al., 2019].
Side effects reported: fatigue, headache, vegetative symptoms; rarely worsening of depression with agitation and restlessness; isolated case reports of myocardial infarction in physically ill patients [source: Hemmeter et al., 2010].
Watch for: relapse after recovery sleep (around 83% of unmedicated and 53% of medicated responders in data cited by Hemmeter et al., 2010).
Example language (illustrative): "On the ward, staff keep you company to stay awake through the night. Many people feel lighter within a day, but it often fades after the next sleep, which is why the team plans the next steps." [synthesis]

Part A2. Triple (combined) chronotherapy, as the team delivers it

Purpose: to keep the rapid response of sleep deprivation by adding sleep phase advance and bright light therapy, with usual medication continued [source: Gottlieb et al., 2019; UCL meta-analysis].
Versions: the UCL meta-analysis notes that not every variant fits the strict "triple chronotherapy" definition and uses "chronotherapy" for the broader family; versions differ in total versus partial deprivation, repeated cycles and the use of blue-blocking glasses [source: UCL meta-analysis]. Named programmes include the San Raffaele ward programme (Benedetti and colleagues; case series 2001, 2005, 2014), the randomised trial by Wu and colleagues (2009) and the Medical University of South Carolina pilot in suicidal inpatients (Sahlem and colleagues, 2014) [source: UCL meta-analysis; Gottlieb et al., 2019; NYSPI protocol #7361]. This guide does not reproduce any of their schedules.
What happens (descriptive): a period of supervised wakefulness, then a shifted sleep period that is moved back towards the usual time over the following days, with bright light therapy given as the team prescribes [source: Gottlieb et al., 2019; UCL meta-analysis]. Guidelines and protocols specify light intensity, timing and duration; these are for the prescriber or sleep specialist.
Outcomes as sources state: in pooled randomised trials, response at day 5 to 7 was 33% with chronotherapy versus 1.5% with controls; open case series showed a weighted response of about 62%; unipolar and bipolar effects were similar; trial effects appeared to fade by weeks 7 to 9 and the authors say no firm conclusion about durability can be drawn [source: UCL meta-analysis].
Watch for: bipolar switch (4 of 388 bipolar patients, most on lithium); side effects were not reported systematically and may be under-reported [source: UCL meta-analysis].
Example language (illustrative): "After the night awake, the team moves your sleep times and adds bright light to help hold on to the improvement. They set every timing; you just follow their plan." [synthesis]

Part A3. Stabilising co-treatments (named only)

What sources name: lithium, antidepressants (mostly serotonergic), bright light, sleep phase advance and pindolol were each reported to prolong the early response; repeated sleep deprivation and rTMS had mixed results; caffeine, modafinil and flumazenil were used only in research to keep patients awake [source: Gottlieb et al., 2019; Hemmeter et al., 2010]. Lithium or other prophylactic medication is reported to reduce switching [source: Hemmeter et al., 2010]. Combining sleep deprivation with mood medication such as lithium was associated with remission at three months in bipolar depression [source: Ramirez-Mahaluf et al., 2020].
Your stance: all decisions about these belong to the prescriber. Name them only to help the client understand the plan and their questions; never suggest starting, stopping or changing any medicine.
Example language (illustrative): "The team may keep or add medicines such as lithium to help the improvement last. Any question about your medicines is for Dr X." [synthesis]
Watch for: hopes that chronotherapy will replace medication. Working: medication questions go to the prescriber. [synthesis]

Part A4. Selection, contraindications and pre-treatment checks (team)

Contraindications and cautions as sources give them: acute mania or mixed state (contraindicated) [source: Gottlieb et al., 2019]; epilepsy ("the main contraindication") [source: Hemmeter et al., 2010]; somatic illness that could be destabilised by the stress of staying awake [source: Hemmeter et al., 2010]; rapid cycling (much higher switch rate) [source: Hemmeter et al., 2010]. A US research protocol for a light-and-sleep regimen excluded bipolar disorder, psychosis history, unstable medical illness, recent substance use disorder, uncontrolled hypertension and pregnancy, and its consent form named retinal conditions as excluding light therapy, with retinal screening first [source: NYSPI protocol #7361]. These are one protocol's criteria, not general rules [uncertain].
Checks described: structured diagnostic interview, hypomania interview, depression and global ratings, physical examination, blood and urine tests, ECG and pregnancy testing in the NYSPI protocol [source: NYSPI protocol #7361].
Psychotherapist's part: share relevant history you hold (with consent): past hypomanic episodes, seizures, substance use, eye problems, physical illness, pregnancy plans [synthesis].
Example language (illustrative): "Before they start, the team will check things like seizures, mood highs and your eyes. Is there anything in your history you'd want them to know?" [synthesis]
Watch for: undisclosed seizures, hypomanic spells or eye problems. Working: the team has the full history. [synthesis]

Part A5. Monitoring during and after (team)

What sources describe: repeated mood ratings; study psychiatrists monitoring suicidality and worsening, with hospitalisation or emergency referral available; stopping if overt suicidality emerges, hospitalisation is needed or the patient withdraws; continued ratings for months afterwards and help finding an ongoing treater [source: NYSPI protocol #7361; Gottlieb et al., 2019]. Most studies did not track tolerability and switching systematically [source: Gottlieb et al., 2019].
Risks named in a consent form: remaining depressed or worsening and suicide risk; mania or hypomania, especially if bipolar disorder is undiagnosed; drowsiness (do not drive when sleepy); overstimulation, headache, nausea or eye irritation from light; unlikely retinal damage [source: NYSPI protocol #7361].
Example language (illustrative): "The team will keep checking your mood during and after the course. If you feel much worse or unusually high, tell them straight away." [synthesis]
Watch for: worsening mood or suicidality between ratings, and drowsiness while driving. Working: concerns reach the team quickly. [synthesis]

Part B: the psychotherapist's interventions. The sources say little about psychotherapists' roles in chronotherapy; the steps below are [synthesis] built on the clinical facts cited in Part A, unless a source is given.

B1. Recognising when to raise a psychiatric review

Purpose: make sure a client who might be a candidate is assessed by the right team, without promising the treatment.
Steps: (1) Note features the sources link to response or to a rapid-response need: severe or treatment-resistant depressive episode, bipolar depression, marked diurnal variation, melancholic features, high suicidality [source: Hemmeter et al., 2010; Gottlieb et al., 2019]. (2) Note red flags that make it inappropriate: current hypomania, mania or mixed features, seizure history [source: Gottlieb et al., 2019; Hemmeter et al., 2010]. (3) Raise it with the client as a question for their psychiatrist, not a recommendation. (4) With consent, write to the prescriber with your observations.
Example language (illustrative): "Some hospital teams use a supervised sleep-and-light treatment for severe depression. Whether it fits you is a medical question. Would you like me to raise it with Dr X?"
Watch for: the client hearing "skip sleep to feel better". Correct this at once (see B10).

B2. Referral and collaborative care

Purpose: a shared plan between you, the psychiatrist and the ward.
Steps: (1) Get written consent to share information. (2) Send a concise referral note: diagnosis as you understand it, episode history, any past hypomania, seizures, substance use, physical or eye problems, suicide risk and current safety plan. (3) Agree who the client contacts in a crisis during and after the course. (4) Ask whether you can have brief contact during the inpatient stay and how observations reach the team. (5) Agree a discharge handover meeting or letter.
Example language (illustrative, to the team): "I can offer sessions before admission and resume weekly work after discharge. Who should I call if I notice hypomanic signs?"
Watch for: unclear lines of responsibility; settle them in writing.

B3. Psychoeducation

Purpose: help the client understand what the treatment is, why it is done in hospital and what to expect.
Steps: (1) Explain the idea in plain words: depression is linked to disturbed body-clock rhythms; a supervised night awake can lift mood quickly; light and a shifted sleep period are added to hold the improvement [source: Gottlieb et al., 2019; UCL meta-analysis]. (2) Be clear that the lift is often temporary and that a dip after recovery sleep is common and expected [source: Hemmeter et al., 2010]. (3) State the evidence honestly: promising, rapid, but based on small and mostly uncontrolled studies [source: Gottlieb et al., 2019]. (4) Refer all practical questions on timing, light and medication to the team.
Example language (illustrative): "Many people feel better within a day or two. For many that improvement fades after normal sleep, which is why the team adds other steps. A dip would not mean you have failed."
Watch for: overly high hopes; misunderstanding that it replaces medication.

B4. Informed-consent and shared-decision support

Purpose: support a free, informed choice; the psychiatrist obtains consent.
Steps: (1) Help the client write down questions for the team: benefits, risks (switch to mania or hypomania, worsening, sleepiness, light side effects, seizures if relevant), alternatives, what happens if it does not work, right to stop [source: NYSPI protocol #7361; Gottlieb et al., 2019]. (2) Use teach-back to check understanding. (3) Explore values and fears without steering. (4) If you doubt capacity (for example severe psychomotor slowing, psychotic features), tell the team; capacity assessment is theirs. Research protocols required documented capacity assessment [source: NYSPI protocol #7361].
Example language (illustrative): "Can you tell me in your own words what the team said could go wrong, and what you would do if it happened?"
Watch for: consent given out of desperation or pressure from family; slow the process down and involve the team.

B5. Preparing for and supporting the client through the protocol

Purpose: reduce distress and help the client follow the team's plan.
Steps: (1) Before admission, talk through what a long supervised night may feel like (tiredness, irritability, boredom, odd emotions). (2) Plan, with the client, low-demand activities they would like for the ward night (the team decides what is allowed). (3) Repeat the team's own instruction on naps without adding your own rules; the sources link naps and microsleeps to weaker response [source: Hemmeter et al., 2010]. (4) If the ward allows contact, offer brief supportive check-ins focused on coping and on noticing changes. (5) Help the client note mood, sleep and energy changes to share with staff.
Example language (illustrative): "Whatever the night is like, notice it and tell the nurses. You do not have to manage it alone."
Watch for: exhaustion-related agitation or worsening depression, which sources report rarely [source: Hemmeter et al., 2010]; tell staff.

B6. Monitoring for mania, hypomania and mixed states

Purpose: early detection of a switch, the main psychiatric risk [source: Gottlieb et al., 2019; UCL meta-analysis].
Steps: (1) At every contact during and after the course, ask about reduced need for sleep, racing thoughts, pressured speech, overspending, risky plans, irritability and mixed features (agitation with despair). (2) Ask a relative, with consent, what they notice. (3) Report any sign to the prescriber or ward the same day; do not wait for the next session. (4) Record what you observed and whom you told.
Example language (illustrative): "Feeling better is good news. I also need to ask: are you sleeping less but feeling full of energy, or finding your thoughts racing?"
Watch for: confusing a healthy response with hypomania; you do not have to decide, just report. Higher risk with rapid cycling [source: Hemmeter et al., 2010].

B7. Suicide-risk monitoring and safety planning

Purpose: keep the client safe across the rapid changes of the course.
Steps: (1) Before admission, review or write a safety plan with the client (warning signs, coping steps, people and services to contact, making the environment safer through storage or removal of means). (2) Assess suicidality at each contact with your usual structured approach. (3) Pay special attention after recovery sleep and in the weeks after discharge, when an early lift may fade [synthesis]. (4) Share risk changes with the team at once; protocols stop or escalate when overt suicidality emerges [source: NYSPI protocol #7361].
Example language (illustrative): "If the improvement fades, some people feel more hopeless than before. If that happens, what is the first thing on your plan?"
Watch for: sudden calm with withdrawal, or renewed hopelessness after a short improvement.

B8. Working with relapse after recovery sleep

Purpose: prevent a temporary dip from becoming demoralisation.
Steps: (1) Remind the client that relapse after recovery sleep is the main known limitation [source: Hemmeter et al., 2010; Gottlieb et al., 2019]. (2) Use the brief improvement as information: what felt different, what they could do, what they want back. (3) Link the dip to the team's plan for consolidation (which is theirs to adjust). (4) Validate disappointment and re-check suicide risk (B7).
Example language (illustrative): "For a day you had energy back. That tells us something about what is still possible. Let's keep hold of that while the team works on holding the gain."
Watch for: self-blame, hopelessness, or a wish to repeat sleep deprivation alone at home (B10).

B9. Adherence and ambivalence about co-treatment

Purpose: explore the client's feelings about medication that the team uses to stabilise response (for example lithium, as sources name it) without advising any change.
Steps: (1) Ask what the client knows and feels about the medicines in the plan. (2) Reflect ambivalence without arguing. (3) Encourage the client to take concerns, side effects or wishes to stop to the prescriber, and offer to help them prepare. (4) If the client reports side effects or warning signs, pass them on to the prescriber (with consent, or under your safety duties).
Example language (illustrative): "It sounds as if part of you would rather not take it. That is worth a proper conversation with Dr X. Shall we write down what you want to ask?"
Watch for: the client hoping chronotherapy will let them stop medication; route to the prescriber.

B10. Responding to interest in self-administered sleep deprivation

Purpose: prevent unsupervised attempts.
Steps: (1) Ask directly whether the client has tried or plans to stay awake at home to lift mood. (2) Explain that sources describe it only as a supervised medical procedure [source: Sleep Med Rev 2007 abstract], with risks of mania or mixed states, seizures in people with epilepsy, physical strain in illness, and a likely crash after recovery sleep [source: Gottlieb et al., 2019; Hemmeter et al., 2010]; add sleepiness-related accident risk such as drowsy driving [source: NYSPI protocol #7361 consent]. (3) Offer the alternative: raise it with the psychiatrist (B1). (4) If they have already tried it, ask about mood changes since and screen for hypomania and suicidality; inform the prescriber.
Example language (illustrative): "This is something hospitals do with a team watching around the clock, because it can trigger mania or seizures. Please don't try it alone. Let's ask your psychiatrist instead."
Watch for: online "wake therapy" or "biohacking" advice; keep the conversation curious, not shaming.

B11. Rhythm-focused psychotherapy and relapse prevention after the course

Purpose: support the stability of sleep-wake and daily rhythms, which the course aims to reset, and reduce relapse.
Steps: (1) In bipolar disorder, consider interpersonal and social rhythm therapy (IPSRT), for which the ISBD review reports evidence of faster recovery and relapse prevention, rated third-line in CANMAT/ISBD guidance [source: Gottlieb et al., 2019]. The clinician's manual lists a chapter on social rhythm therapy [source: Wirz-Justice et al., 2009 contents]. (2) Track daily routines (waking, first contact, meals, activity, bedtime) and their link to mood, in line with the team's sleep instructions. (3) Identify rhythm disruptors (shift work, travel, night-time screen use, conflict, substance use) and plan responses. (4) Build an early-warning sign plan for both depression and hypomania, shared with the prescriber. (5) Keep sleep advice consistent with the team's or sleep specialist's guidance; do not prescribe light or sleep timing yourself.
Example language (illustrative): "Your body clock seems to matter a lot for your mood. Let's look at which parts of your day you can keep steady, and what knocks them off course."
Watch for: rhythm drift in the weeks after discharge; durability of response is unresolved [source: UCL meta-analysis].

B12. Integrating psychotherapy before, during and after

Purpose: keep psychological treatment continuous across the admission.
Steps: (1) Before: pause demanding trauma or exposure work during the acute course; focus on preparation, consent support and safety planning. (2) During: brief supportive contacts only, if the ward permits. (3) After: resume the main therapy (for example CBT, behavioural activation, IPT or IPSRT as indicated) once mood and sleep are stable, and use the client's experience of rapid change in the work. (4) Hold a discharge review with the team: who monitors what, crisis pathway, follow-up ratings. (5) If response fades, return to the referral question with the psychiatrist rather than stopping therapy.
Example language (illustrative): "While you are on the ward, our sessions will be short and practical. Once you are home, we will pick up the longer work again."
Watch for: the client or family treating chronotherapy as the whole treatment; frame it as one part of a plan.

5. Handling problems

The sources do not address psychotherapy-specific problems; everything below is [synthesis] unless a source is given.

Client wants the treatment but the team declines or it is unavailable. Validate the disappointment; ask the psychiatrist to explain the reason (for example a contraindication such as epilepsy or a mixed state [source: Hemmeter et al., 2010; Gottlieb et al., 2019]); refocus on other options the team offers and on psychotherapy. Check for any plan to try it alone (B10).
Client was told it is "the fastest antidepressant" and expects a cure. Balance the message: rapid response is common but often fades, and durability is unproven [source: Hemmeter et al., 2010; UCL meta-analysis].
Non-response. Many patients do not respond [source: Hemmeter et al., 2010]. Normalise this, check suicide risk, and support the client in discussing next steps with the psychiatrist; avoid any suggestion that they did it "wrong".
Relapse after recovery sleep or a nap. Expected in many cases [source: Hemmeter et al., 2010]. Use B8; avoid blame (including the client blaming themselves for dozing off), and pass the information to the team.
Overwhelm, irritability or distress during the wake period. Brief grounding and validation; ask staff for support; sources report rare worsening with agitation [source: Hemmeter et al., 2010]. Never encourage the client to break or extend the protocol; that is the team's call.
Possible switch (euphoria, sleeplessness without tiredness, risky plans) or mixed features. Report the same day to the prescriber or ward; involve family with consent; pause insight-oriented work. Do not try to judge whether it is "just recovery".
Rising suicidality or a hopeless crash after a brief lift. Follow your usual risk procedures: structured assessment, update the safety plan, contact the team or emergency services as indicated; protocols stop or escalate in this case [source: NYSPI protocol #7361].
Client asks you to help them do it at home, or reports doing it. Use B10; inform the prescriber; screen for hypomania and suicidality.
Ambivalence about lithium or other co-treatment. Use B9; never advise changes; route to the prescriber.
Rupture: client feels you "sent them to hospital" or kept them from the treatment. Name the rupture, take your share, explain your role (raising questions and supporting choice, not deciding medical treatment), and repair before going on.
Family pressure to accept or refuse. Hold a session (with consent) to give balanced information and to clarify that the decision is the client's, with the psychiatrist.
Undiagnosed bipolar features emerge. Consent forms note higher mania risk in undiagnosed bipolar disorder [source: NYSPI protocol #7361]. Share any history of hypomanic periods with the team before the course.
Shift workers or clients with irregular rhythms after discharge. Work on what can be kept regular; ask the sleep specialist or prescriber how to fit the team's instructions to their life; do not improvise light or sleep timing.
Eye problems or concern about light. Refer questions to the team; one consent form named retinal conditions as an exclusion and screened the retina first [source: NYSPI protocol #7361].
Physical illness or older age. Make sure the team knows about heart disease, hypertension and other medical conditions; sources cite rare cardiac events in somatically ill patients [source: Hemmeter et al., 2010].

Sources

Sources:

Books and papers cited as further reading (not drawn on in full):

Wirz-Justice A, Benedetti F, Terman M (2009). Chronotherapeutics for Affective Disorders: A Clinician's Manual for Light and Wake Therapy. Basel: Karger. A second edition (2013) is listed by the publisher [uncertain].
Wu JC and colleagues (2009), randomised trial of combined chronotherapy, known here only through the ISBD review and the UCL meta-analysis [uncertain].
Sahlem GL and colleagues (2014), open pilot of adjunctive triple chronotherapy in suicidal depressed inpatients, known here only through the NYSPI protocol's background section [uncertain].
Benedetti F and colleagues, San Raffaele case series (2001, 2005, 2014), known here only through the UCL meta-analysis [uncertain].

← Previous · IX-033Dawn simulation Next · IX-035 →Dark therapy and blue-light blocking